CCL2 and endometrial cancer: Despite the dominant role of the CCL2-CCR2 axis in TAM recruitment, CCL2 deletion resulted in an approximately 60% TAM reduction in mouse models of endometrial cancer 14, suggesting the involvement of additional chemoattractant signals to attract TAMs.